Skip to main content

Cyteir Therapeutics, Inc.

CYTDelisted Mar 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001662244

Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in Cyteir Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
+2 vs. Q2 2023
Shares held
16.3M
+289.8K (+1.8%) vs. Q2 2023
Total value
$46.3M
+$4.67M (+11.2%) vs. Q2 2023
New holders
11
10 more added
Sold out
9
9 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 41 institutions
Q1 2021: 0 institutionsQ2 2021: 33 institutionsQ3 2021: 38 institutionsQ4 2021: 48 institutionsQ1 2022: 52 institutionsQ2 2022: 45 institutionsQ3 2022: 37 institutionsQ4 2022: 30 institutionsQ1 2023: 32 institutionsQ2 2023: 39 institutionsQ3 2023: 41 institutionsQ4 2023: 38 institutionsQ1 2024: 4 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2023: $46.3M
Q1 2021: $0Q2 2021: $352.6MQ3 2021: $344.1MQ4 2021: $253.4MQ1 2022: $83.8MQ2 2022: $56.8MQ3 2022: $34.6MQ4 2022: $28.5MQ1 2023: $23.9MQ2 2023: $41.7MQ3 2023: $46.3MQ4 2023: $38.9MQ1 2024: $11.2MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CYT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20244$11.2M
Q4 202338$38.9M
Q3 202341$46.3M
Q2 202339$41.7M
Q1 202332$23.9M
Q4 202230$28.5M
Q3 202237$34.6M
Q2 202245$56.8M
Q1 202252$83.8M
Q4 202148$253.4M
Q3 202138$344.1M
Q2 202133$352.6M
Q1 20210$0

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Cyteir Therapeutics, Inc.; share changes are against Q2 2023.

Institutions holding CYT in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Qube Research & Technologies Ltd4$110.00%+4New
Wells Fargo & Company139$3950.00%+37+36.3%Added
JPMorgan Chase & Co496$1.41K0.00%00.0%Unchanged
Wolverine Asset Management LLC570$1.62K0.00%+570New
Morgan Stanley1,000$2.84K0.00%−4,972−83.3%Reduced
Lindbrook Capital, LLC2,006$5.70K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)6,917$19.6K0.00%+5,211+305.5%Added
Vazirani Asset Management LLC15,770$44.8K0.07%−140,365−89.9%Reduced
Charles Schwab Investment Management Inc15,972$45.4K0.00%00.0%Unchanged
Boston Family Office LLC24,197$69.0K0.01%00.0%Unchanged
Caas Capital Management LP26,175$74.3K0.02%−8,361−24.2%Reduced
Wittenberg Investment Management, Inc.28,588$81.2K0.03%+28,588New
Northern Trust Corp34,189$97.1K0.00%+15,205+80.1%Added
State Street Corp46,153$131.1K0.00%+22,300+93.5%Added
Squarepoint Ops LLC50,878$144.5K0.00%+50,878New
CSS LLC57,054$162.0K0.01%−3,400−5.6%Reduced
Pale Fire Capital SE57,597$163.6K0.02%00.0%Unchanged
Marquette Asset Management, LLC67,990$193.1K0.05%00.0%Unchanged
Virtu Financial LLC80,428$228.0K0.02%+80,428New
Bank of America Corp80,474$228.5K0.00%00.0%Unchanged
BlackRock Inc.85,584$243.1K0.00%−2,823−3.2%Reduced
Renaissance Technologies LLC104,649$297.0K0.00%−35,151−25.1%Reduced
RBF Capital, LLC117,295$333.1K0.02%00.0%Unchanged
Alta Fundamental Advisers LLC117,346$333.3K0.19%+117,346New
Cantor Fitzgerald, L. P.132,496$376.3K0.01%+400+0.3%Added
Aldebaran Capital, LLC143,739$408.2K0.42%00.0%Unchanged
Geode Capital Management, LLC163,537$464.6K0.00%+44,505+37.4%Added
Bulldog Investors, LLP200,000$568.0K0.20%+200,000New
Acuitas Investments, LLC329,164$934.8K0.55%−90.0%Reduced
Walleye Capital LLC353,916$1.01M0.01%+353,916New
Laurion Capital Management LP359,500$1.02M0.03%00.0%Unchanged
Gabelli & Co Investment Advisers, Inc.416,200$1.18M0.19%+416,200New
Gabelli Funds LLC442,638$1.26M0.01%+442,638New
Vanguard Group Inc640,780$1.82M0.00%+55,997+9.6%Added
Novo Holdings A/S676,379$1.92M0.14%−2,986,257−81.5%Reduced
FMR LLC826,758$2.35M0.00%−1,109−0.1%Reduced
VR Advisory Services Ltd1,072,968$3.05M1.08%+1,072,968New
Anson Funds Management LP1,324,114$3.76M1.25%+172,452+15.0%Added
OUP Management Co., LLC2,459,572$6.99M15.71%00.0%Unchanged
Newtyn Management, LLC2,500,444$7.10M1.75%+1,142,395+84.1%Added
BML Capital Management, LLC3,250,008$9.23M8.51%+80.0%Added
Western Standard LLC0$00.00%−524,050−100.0%Sold out
Evercore Wealth Management, LLC0$00.00%−146,676−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−25,900−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−21,064−100.0%Sold out
Millennium Management LLC0$00.00%−20,494−100.0%Sold out
UBS Group AG0$00.00%−5,267−100.0%Sold out
FNY Investment Advisers, LLC0$00.00%−5,297−100.0%Sold out
Royal Bank of Canada0$00.00%−888−100.0%Sold out
Federated Hermes, Inc.0$00.00%−208−100.0%Sold out